Novel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 706-709

  Nabi, M Olad ^a   Mirabzadeh, A ^a   Feizzadeh, G ^a   Khorram Khorshid, H R ^a   Karimlou, M ^a   Zarif Yeganeh, M ^a   Asgharian, A M ^a   Najmabadi, H ^a   Ohadi, M ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Calreticulin; Mutation; Promoter; Regulatory; Schizoaffective

Indexed keywords

CALRETICULIN;

ADULT; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOAFFECTIVE PSYCHOSIS;

BINDING SITES; CALRETICULIN; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; EXONS; HUMANS; IRAN; MODELS, GENETIC; MUTATION; PROMOTER REGIONS, GENETIC; PSYCHOTIC DISORDERS;

EID: 77349122597     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31036     Document Type: Article

References (10)

1. Aghajani A, Rahimi A, Fadai F, Ebrahimi A, Najmabadi H, Ohadi M. 2006. A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia. Am J Med Genet Part B 141B: 294-295.
2. Hamshere ML, Bennett P, Williams N, Segurado R, Cardno A, Norton N, Lambert D, Williams H, Kirov G, Corvin A, Holmans P, Jones L, Jones I, Gill M, O'Donovan MC, Owen MJ, Craddock N. 2005. Genomewide linkage scan in schizoaffective disorder: Significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 62:1081-1088.
3. Higashino A, Kageyama T. 2008. Development-dependent expression of calreticulin in the brain and other tissues of the Japanese monkey, Macaca fuscata. J Med Primatol 37:303-310.
4. Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T, Kato T. 2005. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 25:5376-5381.
5. Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama Y, Yoshikawa T, Kato T. 2006. A family-based and case-control association study of SOX10 in schizophrenia. Am J Med Genet Part B 141B:477-481.
6. Jalali S, Aghasi M, Yeganeh B, Mesaeli N. 2008. Calreticulin regulates insulin receptor expression and its downstream PI3 Kinase/Akt signalling pathway. Biochem Biophys Acta 1783:2344-2351.
7. Kim AJ, Shi Y, Austin RC, Werstuck GH, Lake CR, Hurwitz N. 2007. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci 118:89-99.
8. Nunes A, Ohadi M, Rahimi A, Aghajani A, Najmabadi H, Curraisa A, Soriano S. 2008. A mutation in the calreticulin gene promoter in a family case of schizoaffective disorder leads to its aberrant transcriptional activation. Brain Res 1239:36-41.
9. Perälä J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppä T, Härkänen T, Koskinen S, Lönnqvist J, 2007. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 64:19-28.
10. Stolt CC, Schlierf A, Lommes P, Hillgartner S, Werner T, Kosian T, Sock E, Kessaris N, Richardson WD, Lefebvre V, Wegner M. 2006. SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function. Dev Cell 11:697-709.